Showing results (61-70 of 226) with videos related to

Sort By:
Pageof 23
British Journal of Clinical Pharmacology|January 3, 2001
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepirideM Niemi, K T Kivistö, J T Backman, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2Marika T Granfors, Janne T Backman, Jouko Laitila, et al.
European Journal of Clinical Pharmacology|February 1, 2006
Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinideLauri I Kajosaari, Tiina Jaakkola, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|March 1, 2002
Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomesXia Wen, Jun-Sheng Wang, Pertti J Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2011
Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrationsAnne M Filppula, Jouko Laitila, Pertti J Neuvonen, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effectT Varis, K T Kivistö, J T Backman, et al.
Pediatric Nephrology (Berlin, Germany)|March 18, 2005
Cyclosporine A monitoring--how to account for twice and three times daily dosingSamuel Fanta, Janne T Backman, Paula Seikku, et al.
Basic & Clinical Pharmacology & Toxicology|September 24, 2005
Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicinLauri I Kajosaari, Jouko Laitila, Pertti J Neuvonen, et al.
British Journal of Pharmacology|October 22, 2011
Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substratesA M Filppula, J Laitila, P J Neuvonen, et al.
Pharmacological Reviews|January 2, 2016
Role of Cytochrome P450 2C8 in Drug Metabolism and InteractionsJanne T Backman, Anne M Filppula, Mikko Niemi, et al.
Pageof 23